Home Newsfeeds EU Regulators Will Not Appeal Qualcomm Ruling

EU Regulators Will Not Appeal Qualcomm Ruling

-Reuters

byBenzinga Newsdesk

September 9, 2022

1 minute read

-Reuters

Silo Pharma Announces Data On SPC-15 For PTSD And Prepares To File Pre-Investigational New Drug Application With FDA

By Benzinga Newsdesk

September 20, 8:29 AM

Pre-IND submission to FDA targeted for first quarter 2024Silo partners with Kymanox for SPC-15ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("the Company"), a developmental

SILO

Roth Capital Maintains Buy on Ligand Pharmaceuticals, Lowers Price Target to $175

By Benzinga Newsdesk

September 2, 9:53 AM

Roth Capital analyst Scott Henry maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and lowers the price target from $185 to $175.

LGND

Southern Q3 EPS $1.31 Beats $1.30 Estimate, Sales $8.38B Beat $6.84B Estimate

By Benzinga Newsdesk

October 27, 6:52 AM

Southern (NYSE:SO) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.30 by 0.77 percent. This is a 6.5 percent increase over earnings of $1.23 per share from the same period

Producer Price Index Unexpectedly Falls In February, Swinging Market Expectations Toward Federal Reserve Pause

By Adam Eckert

March 15, 10:04 AM

U.S. producer prices fell more than economists had expected last month in a sign the Federal Reserve's aggressive response to high inflation is starting to take hold.

EU Regulators Will Not Appeal Qualcomm Ruling

Related Posts

Silo Pharma Announces Data On SPC-15 For PTSD And Prepares To File Pre-Investigational New Drug Application With FDA

Roth Capital Maintains Buy on Ligand Pharmaceuticals, Lowers Price Target to $175

Southern Q3 EPS $1.31 Beats $1.30 Estimate, Sales $8.38B Beat $6.84B Estimate

Producer Price Index Unexpectedly Falls In February, Swinging Market Expectations Toward Federal Reserve Pause